Background illustration for clinical trials search

Paid Clinical Trials Grand Rapids

Discover 468 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

for
Diffuse Large B-cell Lymphoma (DLBCL)
Location: Grand Rapids MI, Detroit MI, Noblesville IN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06091865

Phase 3, Recruiting

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

for
Polycythemia Vera
Location: Grand Rapids MI, Columbus OH, Canton OH, Bethesda MD,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07429266

Phase 3, Recruiting

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

for
Breast Neoplasms, Carcinoma, Ductal, Breast,
Location: Grand Rapids MI, Traverse City MI, Dyer IN,
Sponsor: Natera, Inc.

Sex: All

Age: 18+

Code: NCT07214532

Recruiting

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostate Cancer
Location: Grand Rapids MI, Milwaukee WI, Fairfax VA,
Sponsor: Daiichi Sankyo

Sex: Male

Age: 18+

Code: NCT07244341

Phase 1, Recruiting

Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)

for
Small Cell Lung Cancer
Location: Grand Rapids MI, Omaha NE, Orlando FL
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07778316

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Grand Rapids MI, Chicago IL, Niles IL, Cincinnati OH,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase 3, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Grand Rapids MI, Franklin WI, Evanston IL, Chicago IL,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase 3, Recruiting

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

for
Metastatic Colorectal Cancer
Location: Grand Rapids MI, Chicago IL, Brampton, Toronto,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT06252649

Phase 3, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Grand Rapids MI, Ann Arbor MI, Chicago IL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: Grand Rapids MI, Holland MI, Norton Shores MI,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase 2, Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Grand Rapids MI, Ann Arbor MI, Chicago IL, Detroit MI,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase 3, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Grand Rapids MI, Fort Wayne IN, Madison WI, Edgewood KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase 3, Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for
CLL, Chronic Lymphocytic Leukemia, SLL
Location: Grand Rapids MI, London, Cleveland OH, Dayton OH,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase 3, Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: Grand Rapids MI, Evanston IL, Detroit MI, Chicago IL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Grand Rapids MI, Detroit MI, Chicago IL, Hinsdale IL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase 3, Recruiting

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

for
Biliary Tract Cancer
Location: Grand Rapids MI, Chicago IL, Niles IL, Cleveland OH,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06467357

Phase 3, Recruiting

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

for
Gastric Cancer
Location: Grand Rapids MI, New York NY, Baton Rouge LA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05702229

Phase 2, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Grand Rapids MI, Niles IL, Indianapolis IN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

for
Urothelial Cancer, Bladder Cancer
Location: Grand Rapids MI, Niles IL, Peoria IL, Nashville TN,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07129993

Phase 2, Phase 3, Recruiting

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

for
Prostate Cancer
Location: Grand Rapids MI, Commack NY, Providence RI, Quebec,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07192614

Phase 1, Phase 2, Recruiting